CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 41 enrolled
Drug / intervention
Placebo +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01702025
NCT01702025Phase 2Completed
CompareCT.gov

Rapid Acclimatization to Hypoxia at Altitude

Colorado State University·interventional·Posted Oct 5, 2012·Updated Oct 24, 2014

In Brief

A Phase 2 clinical trial evaluating Placebo, Aminophylline, and 2 other interventions for Physiological Function in Low Oxygen Environment. Completed, enrolled 41 participants across 1 site.

Detailed Summary

In low oxygen environments, such as altitude, some adults may become ill and suffer from acute mountain sickness. Further, all adults will find that exercising becomes much more difficult when compared with exercise at lower altitudes (e.g. sea-level). The purpose of this investigation is to study the effects of two drugs that may help people adjust to high-altitude quickly, prevent them from becoming ill and improve their exercise performance. The drugs are Methazolamide and Aminophylline.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPhysiological Function in Low Oxygen Environment
CountriesUnited States
CollaboratorsDefense Advanced Research Projects Agency, University of Colorado, Denver

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 5, 2012
Enrollment StartJun 1, 2012
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 13.7 years ago

Interventions

Placebodrug

Yellow corn meal in gel capsules

Aminophyllinedrug

National Drug Code (NDC) 0143-1020-01

Methazolamidedrug

NDC 0781-1072-01

Aminophylline+Methazolamidedrug

NDC 0143-1020-01 and NDC 0781-1072-01